Growth Metrics

EBR Systems (EBRCZ) Return on Sales (2025 - 2026)

EBR Systems recorded quarterly Return on Sales of 0.07% in Q1 2026, up 51.88% quarter-over-quarter from 0.15% in Q4 2025.

EBR Systems' Return on Sales history runs 2 years deep, the most recent figure standing at 0.07% for Q1 2026.

  • In Q1 2026, Return on Sales changed N/A year-over-year to 0.07%; the TTM figure through Mar 2026 stood at 0.14% (changed N/A YoY), while the FY2025 annual figure was 0.3%, changed N/A from the prior year.
  • Return on Sales came in at 0.07% for Q1 2026 at EBR Systems, up from 0.15% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.07% in Q1 2026 to a low of 0.71% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 EBR Systems - - 184,000.00 -0.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.07%
Dec 31, 2025 -0.15%
Sep 30, 2025 -0.24%
Jun 30, 2025 -0.71%